Washington, Sept. 5 (ANI): Scientists have developed a new form of aspirin that could extend the drug's benefits to people who may be resisting the drug.
Shiqi Peng, Ming Zhao and colleagues note that aspirin lowers cardiovascular disease risk by keeping blood cells called platelets from clumping and forming clots.
Their research group decided to modify aspirin in an effort to make it work for more people.
They linked aspirin to a carrier consisting of a fragment of protein that can transport aspirin directly to damaged parts of blood vessels where clots form.
Experiments with laboratory rats, stand-ins for humans in such early tests, showed that the carrier delivered aspirin to areas of blood vessels where clots were forming.
It released aspirin inside the developing clot and stopped the clot-formation process.
The study has been published in the journal ACS Nano. (ANI)